about
Influence of CAG Repeat Polymorphism on the Targets of Testosterone ActionDifferences in gene expression and cytokine release profiles highlight the heterogeneity of distinct subsets of adipose tissue-derived stem cells in the subcutaneous and visceral adipose tissue in humansTNFα signals via p66(Shc) to induce E-Selectin, promote leukocyte transmigration and enhance permeability in human endothelial cells.Insulin signalling in human adipose tissue.Human adipose tissue precursor cells: a new factor linking regulation of fat mass to obesity and type 2 diabetes?The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis.Human adipose tissue stem cells: relevance in the pathophysiology of obesity and metabolic diseases and therapeutic applications.Pharmacologic agents for type 2 diabetes therapy and regulation of adipogenesis.GLP-1: benefits beyond pancreas.Long-Term Exposure of Pancreatic β-Cells to Palmitate Results in SREBP-1C-Dependent Decreases in GLP-1 Receptor Signaling via CREB and AKT and Insulin Secretory Response.Gut: A key player in the pathogenesis of type 2 diabetes?Exendin-4 protects pancreatic beta cells from palmitate-induced apoptosis by interfering with GPR40 and the MKK4/7 stress kinase signalling pathway.Exendin-4 prevents c-Jun N-terminal protein kinase activation by tumor necrosis factor-alpha (TNFalpha) and inhibits TNFalpha-induced apoptosis in insulin-secreting cells.The p66Shc protein controls redox signaling and oxidation-dependent DNA damage in human liver cells.Correction of intermittent hypoxia reduces inflammation in obese subjects with obstructive sleep apnea.The p66(Shc) redox adaptor protein is induced by saturated fatty acids and mediates lipotoxicity-induced apoptosis in pancreatic beta cells.Involvement of the p66Shc protein in glucose transport regulation in skeletal muscle myoblasts.Role of UBC9 in the regulation of the adipogenic program in 3T3-L1 adipocytes.Insulin signaling in human visceral and subcutaneous adipose tissue in vivo.Abnormalities of insulin-like growth factor-I signaling and impaired cell proliferation in osteoblasts from subjects with osteoporosis.Dehydroepiandrosterone stimulates glucose uptake in human and murine adipocytes by inducing GLUT1 and GLUT4 translocation to the plasma membrane.Fat depot-related differences in gene expression, adiponectin secretion, and insulin action and signalling in human adipocytes differentiated in vitro from precursor stromal cells.GLP-1 Receptor Activation Inhibits Palmitate-Induced Apoptosis via Ceramide in Human Cardiac Progenitor Cells.The Myokine Irisin Is Released in Response to Saturated Fatty Acids and Promotes Pancreatic β-Cell Survival and Insulin Secretion.Long-acting insulin analog detemir displays reduced effects on adipocyte differentiation of human subcutaneous and visceral adipose stem cells.GLP-1 receptor agonist added to insulin versus basal-plus or basal-bolus insulin therapy in type 2 diabetes: A systematic review and meta-analysisDiabetes and cancer: Pathophysiological fundamentals of a ‘dangerous affair’Serum Homocysteine Levels in Men with and without Erectile Dysfunction: A Systematic Review and Meta-AnalysisInsulin and Insulin Receptors in Adipose Tissue DevelopmentErratum to: GLP-1: benefits beyond pancreasErratum to: The p66Shc redox adaptor protein is induced by saturated fatty acids and mediates lipotoxicity-induced apoptosis in pancreatic beta cellsAN ITALIAN SURVEY OF COMPLIANCE WITH MAJOR GUIDELINES FOR L-THYROXINE OF PRIMARY HYPOTHYROIDISMClinical use of a 180-day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetesEfficacy and safety of very low calorie ketogenic diet (VLCKD) in patients with overweight and obesity: A systematic review and meta-analysisComputerized Video-Capillaroscopy Alteration Related to Diabetes Mellitus and Its ComplicationsIrisin increases the expression of anorexigenic and neurotrophic genes in mouse brainEfficacy and safety of GLP-1 receptor agonists as add-on to SGLT2 inhibitors in type 2 diabetes mellitus: A meta-analysisThe Role of Oxidative Stress in Cardiac Disease: From Physiological Response to Injury Factor
P50
Q26784181-D4040BBE-27B9-43E8-B30F-D1B6CDCCCB1CQ34634032-D2A7101F-0802-4DB1-9F15-C851F89DDD5AQ35069855-989CFF83-641E-4268-B485-EAA1C94D4147Q36576533-C2BA6A69-BBB1-4071-A9AD-FCBFDF1269A9Q37603363-40CAE3D0-84F8-402E-AECA-B3CC09255839Q37701606-D8BC00F8-3E33-4E63-AC8E-BDD78C86E642Q38072796-A7836946-5B93-4879-9A95-DDDF7BADEB37Q38110890-42D71C9E-BEE1-492C-80E7-9137105F4472Q38238288-212E4763-FED5-477F-B4EA-B9F9E3E26583Q38781680-D140C9CC-F98E-4770-AF34-C20985A049DEQ39021924-7A723AF6-8521-4AEB-8A8F-3684D3113C0DQ39101720-82DB112F-4F0C-4D5C-BC46-52C84A7640FCQ39729281-CED41352-E53A-4278-BD98-D4DF060C96DFQ41017508-6861FA83-AD29-4D33-835D-A5F269AF836CQ42122618-0A16ABFB-E081-46F3-9D3D-3EFD441AA06CQ42152595-FC5620C8-F198-4671-909F-4CE47EA4D5CFQ42443933-AF7DE4EB-C7F9-45FF-9611-BF0FA7CC86BEQ42477712-2BC80B97-D3BE-4D65-8607-14C1624CD250Q42492668-AED6DC03-2D21-49CD-A40C-D47AA3F8BEC6Q42522498-62F64DBD-BC32-4566-A271-0E251087D35FQ42832931-CB5DC606-6BFF-4B65-B80F-A41FB3E589A9Q46932219-DEAF6770-BF01-4E93-B111-839198CEB7F3Q47761187-4BC4BA84-1A73-409C-9019-BE2B85686817Q48099151-C3FA8AFE-C874-468C-BB77-10F436F4ED47Q50250021-CC52C876-CC2C-4A95-B95B-7F7FC33272CDQ58456989-696B6057-50D6-4364-88EB-2F6ACAB7D211Q58456992-FFCD240E-C5FC-4456-84DB-1EBF02773046Q58796983-58DD47B3-3FD0-4385-908A-6C75D9079CCAQ64276655-3C17C23E-9637-4CE8-A55B-6BABADFFBF3DQ85896027-F5837480-4FAB-417F-AD35-2958A3B38843Q86042540-C2E34559-8D4B-4E52-9387-F4F64AEB06A2Q88918758-AA8F68AA-52A1-4E50-B54B-FA99A919E431Q89617736-CBF62E1E-B89A-46D2-A2A8-C346DB06A5C8Q91200840-37B3E65D-079B-4BC7-8025-8F1529FAD349Q91278668-243C8404-42B0-43EF-BCC1-6F36A5F00FA1Q91337187-0D7C0F1F-69E1-43EE-9871-410DEF87B9B6Q92095965-0F35CA42-2C34-438C-8763-69E31FA23AD2Q96172005-7069F60A-3964-4A0E-B8D6-49D7812F51DF
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Angelo Cignarelli
@ast
Angelo Cignarelli
@en
Angelo Cignarelli
@es
Angelo Cignarelli
@nl
type
label
Angelo Cignarelli
@ast
Angelo Cignarelli
@en
Angelo Cignarelli
@es
Angelo Cignarelli
@nl
prefLabel
Angelo Cignarelli
@ast
Angelo Cignarelli
@en
Angelo Cignarelli
@es
Angelo Cignarelli
@nl
P106
P1153
14021048100
P21
P2798
P31
P496
0000-0001-6477-9031